Table 1. Study Design.
Session 1 | Session 2 | Session 3 | Session 4 | |
---|---|---|---|---|
Capsule | Placebo | Placebo | 0.75 mg/kg MDMA | 1.5 mg/kg MDMA |
Intranasal spray | Placebo | 20 or 40 IU Oxytocin | Placebo | Placebo |
The order of drugs was randomized across subjects. All participants received both doses of MDMA and placebo, and one active oxytocin dose (20 IU (N=43) or 40 IU (N=22)).